[HTML][HTML] Molecular cloning, cDNA sequence, and bacterial expression of human glutamine: fructose-6-phosphate amidotransferase.

GL McKnight, SL Mudri, SL Mathewes… - Journal of Biological …, 1992 - Elsevier
GL McKnight, SL Mudri, SL Mathewes, RR Traxinger, S Marshall, PO Sheppard, PJ O'hara
Journal of Biological Chemistry, 1992Elsevier
Glutamine: fructose-6-phosphate amidotransferase (GFAT) has recently been shown to be
an insulin-regulated enzyme that plays a key role in the induction of insulin resistance in
cultured cells. As a first step in understanding the molecular regulation of this enzyme the
human form of this enzyme has been cloned and the functional protein has been expressed
in Escherichia coli. A 3.1-kilobase cDNA was isolated which contains the complete coding
region of 681 amino acids. Expression of the cDNA in E. coli produced a protein of …
Glutamine:fructose-6-phosphate amidotransferase (GFAT) has recently been shown to be an insulin-regulated enzyme that plays a key role in the induction of insulin resistance in cultured cells. As a first step in understanding the molecular regulation of this enzyme the human form of this enzyme has been cloned and the functional protein has been expressed in Escherichia coli. A 3.1-kilobase cDNA was isolated which contains the complete coding region of 681 amino acids. Expression of the cDNA in E. coli produced a protein of approximately 77 kDa and increased GFAT activity 4.5-fold over endogenous bacterial levels. Recombinant GFAT activity was inhibited 51% by UDP-GlcNAc whereas bacterial GFAT activity was insensitive to inhibition by UDP-GlcNAc. On the basis of these results we conclude that: 1) functional human GFAT protein was expressed, and 2) the cloned human cDNA encodes both the catalytic and regulatory domains of GFAT since the recombinant GFAT was sensitive to UDP-GlcNAc. Overall, the development of cloned GFAT molecular probes should provide new insights into the development of insulin resistance by allowing quantitation of GFAT mRNA levels in pathophysiological states such as non-insulin-dependent diabetes mellitus and obesity.
Elsevier